Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Protecting Cancer Patients against COVID-19: One Year from Vaccine Approvals

ESMO-Webinar-Series-Protecting-Cancer-Patients-1000x250-One-Year-From-Vaccine-Approvals
Live on
16 Feb 2022 at 18:30 CET

It is with great pleasure that I invite you to participate in the first webinar of a new ESMO Webinar Series which will focus on protection of cancer patients against COVID-19-related morbidity and mortality and summarise the current evidence available one-year post the approval of the COVID-19 vaccines.

This webinar series aims to provide an overview of prognostication algorithms for COVID-19 in cancer patients, as well as an up-to-date overview of the efficacy and safety of COVID-19 vaccines in these patients. Emerging data on monitoring and enhancing vaccine-induced immunity will be highlighted; therapeutic interventions beyond vaccines for the prevention of severe morbidity and mortality in immunosuppressed or high-risk patients will be summarised, and insights into the progress of research on second generation vaccine development will be shared.

I am delighted to announce in the topics of the presentations which will be covered in this webinar. We will begin with a lecture on risk prediction for COVID-19-related morbidity and mortality in cancer patients. This will be followed by a presentation elaborating on the immunogenicity and safety of COVID-19 vaccines in patients with solid cancers. Finally, we will discuss COVID-19 posed uncertainties in relation to positioning of vaccine booster strategies and fighting vaccine inequality in the pandemic.

The programme is designed to provide an overview of current evidence, offer exchange of opinions from top experts and provide important considerations with regard to protection of patients with cancer against COVID-19-related morbidity and mortality

Emanuela Romano
Director, Center for Cancer Immunotherapy, Department of Oncology, Institut Curie, Paris, France

Speakers

Programme

Time

Title

Speaker

5 min

Welcome and Introduction

Emanuela Romano

15 min

Risk prediction for COVID-related morbidity and mortality in patients with cancer: available clinical and laboratory algorithms

Luís Castelo-Branco

20 min

Immunogenicity and safety of vaccines against SARS-CoV2 in patients with solid cancers

Sjoukje Oosting

15 min

Exploring the COVID-19 uncertainties: Positioning vaccine booster strategies and fighting the inequality pandemic

Andrew Ustianowski

15 min

LIVE Q & A

All

A certificate of attendance and 1 ESMO MORA category point will be awarded for live attendance to this event.

Learning objectives:

  • To provide an overview of prognostication algorithms for COVID-19 in patients with cancer.
  • To provide an updated overview of efficacy and safety of anti-SARS-CoV-2 vaccines in patients with cancer.
  • To highlight emerging data on monitoring and enhancing vaccine-induced immunity.
  • To highlight therapeutic interventions beyond vaccines for the prevention of severe morbidity and mortality in immunosuppressed or high-risk patients.
  • To provide insights into research progress on second generation vaccine development.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.